Overview
OneStudyTeam provides a cloud-based software platform for clinical trials, offering researchers and trial coordinators a subscription SaaS to manage and accelerate studies. The StudyTeam platform helps run trials more efficiently by handling protocol management, patient recruitment and retention, and access to diverse patient populations, all through an online system. It differentiates itself by its position within the Reify Health ecosystem and its focus on expanding patient access and speeding enrollment, rather than relying on ad-hoc processes. The company’s goal is to speed the development of new therapies and improve trial outcomes for patients around the world by making trial management easier and more scalable.
Work here?Claim your company
Simplify's take
What believers are saying
- Walmart's 2026 expansion widens Care Access distribution and could feed StudyTeam demand.
- Reify Health's 2026 financing reportedly raised $220 million, extending runway and product investment.
- StudyTeam added diversity reporting and an online learning portal, improving sponsor value and adoption.
What critics are saying
- OneStudyTeam brand is retiring on 2026-08-17, signaling subordination inside Care Access.
- Reify Health's 2022 layoffs cut about 25% after rapid hiring, showing execution fragility.
- Florence, Castor, and RealTime-CTMS pressure StudyTeam on enrollment, eSource, and financial workflows.
What makes OneStudyTeam unique
- StudyTeam powers 10,000+ sites across 100+ countries as of 2026-10-03.
- Care Access integrates recruitment, site support, and decentralized care around StudyTeam.
- Walmart added three 2027 Clinical Trial Centers with Care Access on 2026-10-27.
Help us improve and share your feedback! Did you find this helpful?